Aravind Anjana, Shaji Vineetha, Ahmed Mukhtar, Dagamajalu Shobha, Vijayakumar Manavalan, Prasad Thottethodi Subrahmanya Keshava, Raju Rajesh
Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Front Immunol. 2025 Jun 30;16:1608101. doi: 10.3389/fimmu.2025.1608101. eCollection 2025.
Interleukin-24 (IL-24) is a cytokine belonging to the IL-10 family with immunoregulatory properties. It is known to induce cellular responses in various disease conditions, including inflammatory, infectious diseases, and cancer, in a receptor-dependent and independent manner. IL-24 is induced by both immune and non-immune cells and acts on a vast array of target cells to regulate various biological processes. The antitumor and immunoregulatory properties of IL-24 support its application as a therapeutic agent in a vast array of pathological conditions. Characterizing the molecular events associated with its immunomodulatory properties is essential for evaluating its utility in cancer immunotherapy.
The data related to signaling events induced by IL-24 were then manually annotated and cataloged from the literature pertaining to IL-24 signaling. The cataloged molecular events were then manually drawn based on the topology as a signaling pathway map of IL-24.
Based on the data mined from published literature, we assembled IL-24-regulated signaling events linked to its immunoregulatory and anti-tumor activities. The receptor-ligand interaction of IL-24 regulates multiple downstream signaling cascades, leading to antitumor activities alongside inducing inflammatory reactions and anti-infectious processes. We provide a signaling pathway map of IL-24 consisting of 433 mRNAs/proteins and their 613 signaling events.
We believe this map would serve as a knowledge base for reference and one-go visualization of the signaling events identified to be induced by IL-24. Moreover, this map is made available (https://ciods.in/il24/) for the researchers to explore the role of IL-24 in various pathophysiological conditions through the gene set enrichment of transcriptomics or proteomics datasets from various disease conditions.
白细胞介素-24(IL-24)是一种属于IL-10家族的具有免疫调节特性的细胞因子。已知它在包括炎症、传染病和癌症在内的各种疾病状态下,以受体依赖和非依赖的方式诱导细胞反应。IL-24由免疫细胞和非免疫细胞诱导产生,并作用于大量靶细胞以调节各种生物学过程。IL-24的抗肿瘤和免疫调节特性支持其作为治疗剂应用于多种病理状况。表征与其免疫调节特性相关的分子事件对于评估其在癌症免疫治疗中的效用至关重要。
然后从与IL-24信号传导相关的文献中手动注释并编目与IL-24诱导的信号事件相关的数据。然后根据拓扑结构手动绘制编目的分子事件,作为IL-24的信号通路图。
基于从已发表文献中挖掘的数据,我们组装了与IL-24的免疫调节和抗肿瘤活性相关的IL-24调节的信号事件。IL-24的受体-配体相互作用调节多个下游信号级联反应,除了诱导炎症反应和抗感染过程外,还导致抗肿瘤活性。我们提供了一个由433个mRNA/蛋白质及其613个信号事件组成的IL-24信号通路图。
我们相信这张图将作为一个知识库,用于参考和一次性可视化被确定为由IL-24诱导的信号事件。此外,这张图可在(https://ciods.in/il24/)获取,供研究人员通过来自各种疾病状况的转录组学或蛋白质组学数据集的基因集富集来探索IL-24在各种病理生理状况中的作用。